胸腹腔镜联合下食管癌微创手术临床疗效分析  

Clinical Efficacy Analysis of Thoracoscope and Abdominoscope Combined with Minimally Invasive Esophageal Surgery

作　　者：饶新辉[1] 刘汉云[1] 粱锦崧 

机构地区：[1]中山大学附属梅州市人民医院胸外科,广东梅州514031

出　　处：《黑龙江医学》2015年第4期400-402,共3页Heilongjiang Medical Journal

摘　　要：目的探讨胸腹腔镜联合下食管癌微创手术临床疗效。方法回顾性分析100例接受胸腹腔镜联合下食管癌微创手术患者(观察组)和100例接受开放性手术食管癌患者(对照组)的临床资料。比较两组患者的手术指标、围手术期并发症和近期疗效。结果观察组患者无死亡,对照组患者死亡2例。观察组手术时间(274.7±67.3)min与对照组的(255.4±49.1)min相比无统计学差异(P>0.05),观察组患者术中出血量、患者住院时间、胸管留置时间显著低于对照组。观察组患者清扫淋巴结数与术后并发症发生率与对照组相比无统计学差异(P>0.05)。观察组患者复发率6.3%(6/96)显著低于对照组的17.0%(16/94),P<0.05。观察组患者生存率94.8%(91/96)显著高于对照组的84.0%(79/94)。结论胸腹腔镜联合下食管癌微创手术临床疗效显著可减少患者术中损伤并预防复发。Objective To study in clinical efficacy of thoracoscope and abdominoscope combined with minimally invasive esophageal surgery. Methods The clinical data of 100 patients who received thoracoseope and abdominoscope combined with minimally invasive esophageal surgery and 100 patients who received open operation were retrospectively analyzed. The operation indexes,peri -operative complications and short - term efficacy of the two groups were compared. Results The operation time in observation group was （ 274.7 ± 67.3 ） min which had no significant difference than （ 255.4 ± 49.1 ） rain in control group （ P 〉 0.05 ）. The peri - operative bleeding, the hospital stay time and the chest tube duration were significantly less than the control group. The recurrence rate in observation group was 6.3% （6/ 96 ） which was significantly less than 17.0% （ 16/94 ） in control group （ P 〈 0.05 ）. And the survival rate in observation group was 94.8% （91/96） which was significantly higher than 84.0% （79/94） in control group. Conclusion Thoracoscope and abdominoscope combined with minimally invasive esophageal surgery has a great clinical efficacy.

关 键 词：胸腹腔镜 食管癌微创手术 临床疗效 

分 类 号：R735.1[医药卫生—肿瘤]